Vir and GlaxoSmithKline begin pivotal study of Covid-19 antibody drug
Vir Biotechnology and GlaxoSmithKline announced they are beginning a major study of an antibody drug aimed at treating Covid-19.
News
Were researchers wrong to move the goalposts on remdesivir? In the end, it may not have mattered
Were researchers wrong to move the goalposts on remdesivir? In the end, it may not have mattered. […]
